Leukotriene Antagonists Concept

subject area of

• A dual CysLT1/2antagonist attenuates allergen-induced airway responses in subjects with mild allergic asthma  Academic Article
• A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).  Academic Article
• A systematic review of adverse drug events associated with administration of common asthma medications in children  Academic Article
• Adult Asthma Consensus Guidelines Update 2003  Academic Article
• Anti-allergic therapies: effects on eosinophil progenitors  Academic Article
• Antileukotrienes in the Treatment of Asthma  Academic Article
• Antileukotrienes, asthma pathogenesis and the pharmaceutical industry.  Academic Article
• Asthma in the real world  Academic Article
• Asthma treatment: antileukotriene drugs.  Academic Article
• Can Montelukast Shorten Prednisolone Therapy in Children with Mild to Moderate Acute Asthma? A Randomized Controlled Trial  Academic Article
• Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy  Academic Article
• Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma  Academic Article
• Daily Inhaled Corticosteroid Treatment Should Not Be Prescribed for Mild Persistent Asthma  Academic Article
• Effect of FLAP antagonist MK-0591 on leukotriene production and ozone-induced airway responses in dogs  Academic Article
• Effect of a Leukotriene Antagonist, LY171883, on Cold Air-induced Bronchoconstriction in Asthmatics  Academic Article
• Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma  Academic Article
• Effects of a cysteinyl leukotriene receptor antagonist on eosinophil recruitment in experimental allergic rhinitis  Academic Article
• Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma  Academic Article
• Expression of functional cysteinyl leukotriene receptors by human basophils  Academic Article
• Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma  Academic Article
• From Bench to Bedside  Academic Article
• How much is too much? The treatment of mild asthma  Academic Article
• Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation  Academic Article
• Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction  Academic Article
• Is the Aging Airway Less Responsive to Treatment?  Academic Article
• Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy  Academic Article
• Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor antagonists.  Academic Article
• Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis  Academic Article
• Montelukast and Churg-Strauss syndrome.  Academic Article
• Neural and myogenic effects of leukotrienes C4, D4, and E4 on canine bronchial smooth muscle  Academic Article
• P2X7 Receptor Activation in Rat Brain Cultured Astrocytes Increases the Biosynthetic Release of Cysteinyl Leukotrienes  Academic Article
• Pharmacologic Interventions to Reduce the Risk of Asthma Exacerbations  Academic Article
• Pharmacologic modulation of airway inflammation  Conference Paper
• Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D4 receptor antagonist  Academic Article
• Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects  Academic Article
• Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4–receptor antagonist cinalukast☆☆☆★  Academic Article
• Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma  Academic Article
• Role of Leukotrienes and Leukotriene Receptor Antagonists in Asthma  Academic Article
• Role of leukotrienes and leukotriene receptor antagonist in asthma: new advances.  Academic Article
• Severe chronic asthma  Academic Article
• Single-dose desloratadine and montelukast and allergen-induced late airway responses  Academic Article
• Systemic aspects of allergic disease: the role of the bone marrow  Academic Article
• Temperature sensitivity of suicidal erythrocyte death  Academic Article
• The Effect of Pranlukast on Allergen-induced Bone Marrow Eosinophilopoiesis in Subjects with Asthma  Academic Article
• The September epidemic of asthma exacerbations in children: A search for etiology  Academic Article
• The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects  Academic Article
• The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction  Academic Article
• The effects of montelukast on tissue inflammatory and bone marrow responses in murine experimental allergic rhinitis: interaction with interleukin-5 deficiency  Academic Article
• The treatment of atopic dermatitis and other dermatoses with leukotriene antagonists.  Academic Article
• The use of sputum cell counts to evaluate asthma medications  Academic Article
• Therapeutic strategies to reduce asthma exacerbations  Academic Article
• Treatment of Asthma with Drugs Modifying the Leukotriene Pathway  Academic Article
• Treatment of mild asthma  Academic Article
• What Is New Since the Last (1999) Canadian Asthma Consensus Guidelines?  Academic Article